Tech Company Financing Transactions
Synfini Funding Round
On 7/7/2025, Synfini raised $8.9 million in financing from Ferocity Capital, Foothill Ventures and Gaingels.
Transaction Overview
Company Name
Announced On
7/7/2025
Transaction Type
Venture Equity
Amount
$8,900,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support further hiring in scientific and engineering roles, expansion of its software and automated lab capabilities, and growth of commercial partnerships in areas including GPCR-targeted therapeutics and precision oncology.
Company Information
Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
Undisclosed
Menlo Park, CA Undisclosed
USA
Menlo Park, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Synfini, Inc., a privately held Menlo Park, California-based company, is a pioneer in agile chemistry. Its advanced, automated molecular discovery platform is transforming drug discovery through integrated neuro-symbolic AI, discovery-focused robotic automation, and world-class chemistry data. The patented Synfini platform includes automated chemical synthesis technologies from SRI International. As a commercial enterprise Synfini will provide accelerated molecular discovery to drug hunters and. pharmaceutical companies worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Doug Donzelli
Browse more venture capital transactions:
Prev: 7/7/2025: Lab Thread venture capital transaction
Next: 7/7/2025: Sensifai Health venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs